BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18160616)

  • 1. Low-density lipoprotein specifically binds glycoprotein IIb/IIIa: a flow cytometric method for ligand-receptor interaction.
    Tetik S; Uras F; Ekşioğlu-Demiralp E; Turay Yardimci K
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):210-9. PubMed ID: 18160616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry.
    Faraday N; Goldschmidt-Clermont P; Dise K; Bray PF
    J Lab Clin Med; 1994 May; 123(5):728-40. PubMed ID: 7515093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins.
    Liu CZ; Hur BT; Huang TF
    Thromb Haemost; 1996 Oct; 76(4):585-91. PubMed ID: 8903000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K; Ahmad G; Hsu L; Kamiyama M
    J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets.
    Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of the platelet surface area and surface density of glycoprotein IIb-IIIa of unactivated human platelets of various sizes.
    Leytin V; Shapiro H; Novikov I; Radnay J
    Biochem Biophys Res Commun; 1996 Sep; 226(1):94-100. PubMed ID: 8806597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
    Xiao Z; Théroux P; Frojmovic M
    Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in platelet GPIIb-IIIa activation.
    Faraday N; Goldschmidt-Clermont PJ; Bray PF
    Thromb Haemost; 1997 Apr; 77(4):748-54. PubMed ID: 9134654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of disagregin with the platelet fibrinogen receptor, glycoprotein IIb-IIIa.
    Karczewski J; Connolly TM
    Biochem Biophys Res Commun; 1997 Dec; 241(3):744-8. PubMed ID: 9434779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
    Chiang TM; Zhu J
    Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
    Frojmovic MM; Wong T; Searcy GP
    Thromb Haemost; 1996 Dec; 76(6):1047-52. PubMed ID: 8972030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-binding assays: fibrinogen.
    Cox D
    Methods Mol Biol; 2004; 273():125-38. PubMed ID: 15308798
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on conformational changes of GP IIb/IIIa complex during platelet activation].
    Peng L; Li J; Wu H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):459-61. PubMed ID: 11721407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do glycoproteins IIb/IIIa participate in activation of human platelet s by low density lipoproteins?].
    Bochkov VN; Sorokin EV; Byzova TV; Mazurov AV; Little P; Bobik A; Tkachuk VA
    Biokhimiia; 1995 Aug; 60(8):1187-94. PubMed ID: 7578573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative modification of fibrinogen affects its binding activity to glycoprotein (GP) IIb/IIIa.
    Tetik S; Kaya K; Demir M; Eksioglu-Demiralp E; Yardimci T
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):51-9. PubMed ID: 19903699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation.
    Sloan SM; Brown EB; Liu Q; Frojmovic MM
    Platelets; 2000 Mar; 11(2):99-110. PubMed ID: 10938888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogold-surface replica study of ADP-induced ligand binding and fibrinogen receptor clustering in human platelets.
    Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF
    Am J Anat; 1989; 185(2-3):142-8. PubMed ID: 2773809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.